Skip to main content

Jaw Ching's Form 4 filing

Cytokinetics Inc (CYTK) · filed Apr 6, 2022

Accession no.
0001061983-22-000095
Filed
Apr 6, 2022
Trade date
Apr 4-5, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.02M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jaw ChingCIK 0001710875Officer (SVP Finance & CFO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 4, 2022Common StockMOption exerciseAcquired+15,000$12.10+$181,50082,109Direct
Apr 4, 2022Common StockSSaleDisposed−15,000$40.00−$600,00067,109Direct
Apr 5, 2022Common StockMOption exerciseAcquired+10,000$12.10+$121,00077,109Direct
Apr 5, 2022Common StockSSaleDisposed−10,000$42.00−$420,00067,109Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 4, 2022Common StockMOption exerciseDisposed−15,000$0.00$011,944Direct
Apr 5, 2022Common StockMOption exerciseDisposed−10,000$0.00$01,944Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)